# Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients

> **NCT00428025** · PHASE4 · TERMINATED · sponsor: **Queen's University** · enrollment: 23 (actual)

## Conditions studied

- Pancreatitis

## Interventions

- **DRUG:** diclofenac
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00428025
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428025, "Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00428025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*